2,6-Bis(hydroxymethyl)-p-cresolCAS# 91-04-3 |
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
| Cas No. | 91-04-3 | SDF | Download SDF |
| PubChem ID | 7039 | Appearance | Powder |
| Formula | C9H12O3 | M.Wt | 168 |
| Type of Compound | N/A | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| Chemical Name | 2,6-bis(hydroxymethyl)-4-methylphenol | ||
| SMILES | CC1=CC(=C(C(=C1)CO)O)CO | ||
| Standard InChIKey | KUMMBDBTERQYCG-UHFFFAOYSA-N | ||
| Standard InChI | InChI=1S/C9H12O3/c1-6-2-7(4-10)9(12)8(3-6)5-11/h2-3,10-12H,4-5H2,1H3 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
2,6-Bis(hydroxymethyl)-p-cresol Dilution Calculator
2,6-Bis(hydroxymethyl)-p-cresol Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 5.9524 mL | 29.7619 mL | 59.5238 mL | 119.0476 mL | 148.8095 mL |
| 5 mM | 1.1905 mL | 5.9524 mL | 11.9048 mL | 23.8095 mL | 29.7619 mL |
| 10 mM | 0.5952 mL | 2.9762 mL | 5.9524 mL | 11.9048 mL | 14.881 mL |
| 50 mM | 0.119 mL | 0.5952 mL | 1.1905 mL | 2.381 mL | 2.9762 mL |
| 100 mM | 0.0595 mL | 0.2976 mL | 0.5952 mL | 1.1905 mL | 1.4881 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- 2-Benzoylpyridine
Catalog No.:BCC8562
CAS No.:91-02-1
- 8-Methoxybonducellin
Catalog No.:BCN4453
CAS No.:90996-27-3
- A 83-01
Catalog No.:BCC1319
CAS No.:909910-43-6
- W146
Catalog No.:BCC7723
CAS No.:909725-61-7
- α-CGRP (human)
Catalog No.:BCC5962
CAS No.:90954-53-3
- Cl-HIBO
Catalog No.:BCC7147
CAS No.:909400-43-7
- Erythrocentauric acid
Catalog No.:BCN7683
CAS No.:90921-13-4
- Broussonin E
Catalog No.:BCN4452
CAS No.:90902-21-9
- M871
Catalog No.:BCC5930
CAS No.:908844-75-7
- α-helical CRF 9-41
Catalog No.:BCC5727
CAS No.:90880-23-2
- Aprotinin
Catalog No.:BCC1220
CAS No.:9087-70-1
- Ptelatoside B
Catalog No.:BCN4451
CAS No.:90852-99-6
- Syringol
Catalog No.:BCN3534
CAS No.:91-10-1
- Coumarin
Catalog No.:BCN6309
CAS No.:91-64-5
- Benzoguanamine
Catalog No.:BCC8853
CAS No.:91-76-9
- N,N'-Bis(acetoacetyl)-o-toluidine
Catalog No.:BCC9062
CAS No.:91-96-3
- Fmoc-Arg-OH
Catalog No.:BCC3039
CAS No.:91000-69-0
- Impurity of Calcipotriol
Catalog No.:BCC5388
CAS No.:910133-69-6
- CGI-1746
Catalog No.:BCC1473
CAS No.:910232-84-7
- RGDS peptide
Catalog No.:BCC7694
CAS No.:91037-65-9
- BAY 60-6583
Catalog No.:BCC6197
CAS No.:910487-58-0
- Danshenol C
Catalog No.:BCN6681
CAS No.:910856-25-6
- 8-Epidiosbulbin E acetate
Catalog No.:BCN7812
CAS No.:91095-48-6
- 3,6,19,23-Tetrahydroxy-12-ursen-28-oic acid
Catalog No.:BCN1310
CAS No.:91095-51-1
Synthesis of new Mn19 analogues and their structural, electrochemical and catalytic properties.[Pubmed:30778455]
Dalton Trans. 2019 Apr 9;48(15):4830-4836.
We report the synthesis and structural characterisation of new Mn19 and Mn18M analogues, [MnIII12MnII7(mu4-O)8(mu3-OCH3)2(mu3-Br)6(HLMe)12(MeOH)6]Br2 (2) and [MnIII12MnII6Sr(mu4-O8(mu3-Cl)8(HLMe)12(MeCN)6]Cl2 cluster (3), where H3LMe is 2,6-Bis(hydroxymethyl)-p-cresol. The electrochemistry of 2 and 3 has been investigated and their activity as catalysts in the oxidation of benzyl alcohol has been evaluated. Selective oxidation of benzyl alcohol to benzaldehyde by O2 was achieved using 1 mol% of catalyst with conversions of 74% (2) and 60% (3) at 140 degrees C using TEMPO as a co-catalyst. No partial conversion of benzaldehyde to benzoic acid was observed. The results obtained revealed that different operative parameters - such as catalyst loading, temperature, time, solvent and the presence of molecular oxygen - played an important role in the selective oxidation of benzyl alcohol.
Effect of coordination geometry on the magnetic properties of a series of Ln2 and Ln4 hydroxo clusters.[Pubmed:29334389]
Dalton Trans. 2018 Jan 30;47(5):1726-1738.
A series of three isostructural tetranuclear complexes with the general molecular formula [Ln4(mu3-OH)4(L)4(mu2-piv)4(MeOH)4] (Ln = Gd 1, Dy 2 and Ho 3; LH = [1,3-bis(o-methoxyphenyl)-propane-1,3-dione]) were isolated and unambiguously characterized by single crystal XRD. Under similar reaction conditions, simply changing the co-ligand from pivalate to 2,6-Bis(hydroxymethyl)-p-cresol (LH'3) led to the isolation of dinuclear Ln(iii) complexes with the general molecular formula [Ln2(L)4(mu2-LH'2)2].4DMF (Ln = Gd 4, Dy 5 and Ho 6). Direct current magnetic susceptibility data studies on the polycrystalline sample of 1-6 and the results reveal the existence of weak antiferromagnetic exchange interactions between the lanthanide ions in 1 which is evident from the spin Hamiltonian (SH) parameters (J1 = -0.055 cm(-1) and g = 2.01) extracted by fitting chiMT(T). On the other hand, though complex 4 exhibits weak antiferromagnetic coupling (J1 = -0.048 cm(-1) and g = 1.99) between the Gd(iii) ions, the chiMT(T) data of complexes 5 and 6 unambiguously disclose the presence of ferromagnetic interactions between Dy(iii) and Tb(iii) ions at lower temperature. Magnetization relaxation dynamics studies performed on 2 show frequency dependent out-of-phase susceptibility signals in the presence of an optimum external magnetic field of 0.5 kOe. In contrast, complex 5 shows slow magnetization relaxation with an effective energy barrier (Ueff) of 38.17 cm(-1) with a pre-exponential factor (tau0) of 1.85 x 10(-6) s. The magnetocaloric effect (MCE) of complexes 1 and 4 was extracted from the detailed magnetization measurement and the change in the magnetic entropy (-DeltaSm) of 1 and 4 was found to be 25.57 J kg(-1) K(-1) and 12.93 J kg(-1) K(-1), respectively, at 3.0 K for DeltaH = 70 kOe.
Single crystal-to-single crystal irreversible transformation from a discrete vanadium(V)-alcoholate to an aldehydic-vanadium(IV) oligomer.[Pubmed:20964328]
J Am Chem Soc. 2010 Nov 17;132(45):15842-5.
An unprecedented single crystal-to-single crystal transformation occurs when a binuclear oxovanadium(V) compound [V(V)(2)O(2)(L)(2)] 1 involving 2,6-Bis(hydroxymethyl)-p-cresol (H(3)L) as a bridging ligand is exposed simultaneously to white light and aerial oxygen to generate an oligomeric compound [V(IV)(2)O(2)(L*)(2)] 2 (H(2)L* is 3-hydroxymethyl-5-methylsalicylaldehyde). Each vanadium(V) center in 1 is reduced to vanadium(IV) in 2 at the expense of a two-electron alcohol-to-aldehyde oxidation in the coordinated ligand. The additional electron being released is possibly consumed by molecular oxygen to generate hydrogen peroxide.
A nontwisted, ferromagnetically coupled Mn(III)3O triangular complex from the use of 2,6-bis(hydroxymethyl)-p-cresol.[Pubmed:19166363]
Inorg Chem. 2009 Feb 2;48(3):813-5.
The reaction between Mn(O(2)CMe)(2) x 4 H(2)O and hmcH(3) [hmcH(3) = 2,6-Bis(hydroxymethyl)-p-cresol] in CH(2)Cl(2) in the presence of NEt(3) affords the Mn(III)(3) complex [NEt(3)(CH(2)Cl)](2)[Mn(3)O(hmcH)(3)(hmcH(2))(3)] (1). The anion of 1 contains a [Mn(III)(3)(mu(3)-O)](7+) triangular core, with the central O(2-) ion lying above the Mn(3) plane. The complex is ferromagnetically coupled with a resulting S = 6 ground state.
